市场调查报告书

全球药物研发市场预测

Global Drug Discovery Market Forecast 2019-2027

出版商 Inkwood Research 商品编码 607157
出版日期 内容资讯 英文 167 Pages
商品交期: 2-3个工作天内
价格
Back to Top
全球药物研发市场预测 Global Drug Discovery Market Forecast 2019-2027
出版日期: 2019年08月12日内容资讯: 英文 167 Pages
简介

本报告提供全球药物研发市场相关调查,市场概要,各技术、地区的市场趋势,市场规模的变化与预测,市场促进、阻碍因素以及市场机会、课题分析,竞争情形,主要企业的简介等系统性资讯。

第1章 调查范围

第2章 调查手法

第3章 摘要整理

  • 市场概要
  • 主要调查结果

第4章 市场决策要素

  • 推动市场要素
  • 市场阻碍因素
  • 市场机会
  • 课题

第5章 全球药物研发市场:市场区隔

  • 各技术
    • 定量聚合酵素链锁反应(Q-PCR)
    • DNA微阵列
    • 蛋白质微阵列
    • 高通量筛检(HTS)
    • 质谱分析(MS)
    • 凝胶电泳
    • 层析法
    • 核酸、蛋白质分离
    • 其他技术

第6章 主要分析

  • 波特的五力分析
  • 价值链分析
  • PESTEL分析
  • 市场机会的矩阵

第7章 地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 法国
    • 德国
    • 西班牙
    • 义大利
    • 其他
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 其他
  • 其他地区

第8章 企业简介

  • ASTRAZENECA PLC
  • BAYER AG
  • BOEHRINGER INGELHEIM
  • ELI LILY
  • F. HOFFMANN-LA ROCHE LTD
  • GLAXOSMITHKLINE LLC
  • JOHNSON AND JOHNSON
  • MERCK & CO. INC.
  • PFIZER, INC.
  • SANOFI

图表清单

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 13150

KEY FINDINGS

The global drug discovery market is expected to rise at a CAGR of 8.54% during the forecast period of 2019-2027. In terms of revenue, the global market accounted for $XX million in 2018 and is estimated to reach $83155 million by 2027. The market is primarily driven by factors like rising incidences of chronic diseases across the globe and increasing government funding to various research & development programs.

MARKET INSIGHTS

The global drug discovery market is classified into several segments, such as technology, services, end-users, and drug type. The applications of small molecule drugs in the treatment of chronic disorders is primarily surging the demand for drugs in the market. The rising technological developments and innovations are fueling the drug discovery market at a significant pace. Also, many drug manufacturers, government, and private players are investing in the research & development activities, which further enlarge the global drug discovery market.

REGIONAL INSIGHTS

North America, Asia-Pacific, Europe and Rest of World are the geographical segments of the drug discovery market. By the end of the forecast period, the North American market is anticipated to account for the lion's share of the global market. The U.S is expected to be one of the major contributors to this region owing to high healthcare spending and growing lifestyle-related diseases. Also, the Asia-Pacific market is predicted to register the fastest growth driven by high investments and growing R&D.

COMPETITIVE INSIGHTS

Noted players in the global drug discovery market include AstraZeneca PLC, Pfizer Inc., 3M Company, Antares Pharma, Becton, Dickinson & Company (BD), Eli Lily, Johnson and Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Boehringer Ingelheim, Novartis, Merck & Co. Inc., Sanofi, and GlaxoSmithKline LLC.

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. HIGH PREVALENCE RATES OF MAJOR HEALTH DISORDERS
    • 3.2.2. IMPLEMENTATION OF DRUG DISCOVERY PROGRAMS
    • 3.2.3. BIOINFORMATICS IS THE WIDELY USED DRUG DISCOVERY TECHNOLOGY
    • 3.2.4. SMALL MOLECULE DRUG TYPE CONSTITUTES THE HIGHEST MARKET SHARE
    • 3.2.5. CONTRACT RESEARCH ORGANIZATIONS (CROS) ARE THE FASTEST-GROWING END USER

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. AGING POPULATION
    • 4.2.2. BRANDED DRUGS ARE OUTPERFORMING DUE TO HIGH COST COMPARED TO GENERIC DRUGS
    • 4.2.3. GROWING HEALTHCARE EXPENDITURE
    • 4.2.4. GLOBAL INCREASE IN LIFESTYLE ORIENTED DISEASES & FATALITIES
    • 4.2.5. TECHNOLOGICAL ADVANCEMENT
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. DELAY IN PRODUCT LAUNCHES
    • 4.3.2. POOR ACCESS TO HEALTHCARE SERVICES IN DEVELOPING MARKETS
    • 4.3.3. SHIFT FROM BRANDED TO GENERIC DRUGS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. EXTENSIVE R & D FOR NEW PRODUCT LAUNCHES
    • 4.4.2. INCREASING DEMAND FOR SPECIALTY MEDICINES
    • 4.4.3. RISING INVESTMENT BY PHARMACEUTICAL COMPANIES IN IMPROVING BIG-DATA ANALYTICAL CAPABILITIES
  • 4.5. MARKET CHALLENGES
    • 4.5.1. COST BARRIER FOR LOCAL PEOPLE IN EMERGING ECONOMIES
    • 4.5.2. STRINGENT GOVERNMENT REGULATIONS

5. MARKET BY TECHNOLOGY

  • 5.1. HIGH THROUGHPUT SCREENING
  • 5.2. BIOCHIPS
  • 5.3. BIOINFORMATICS
  • 5.4. PHARMACOGENOMICS AND PHARMACOGENETICS
  • 5.5. COMBINATORIAL CHEMISTRY
  • 5.6. NANOTECHNOLOGY
  • 5.7. SPECTROSCOPY
  • 5.8. METABOLOMICS
  • 5.9. OTHER TECHNOLOGIES

6. MARKET BY DRUG TYPE

  • 6.1. SMALL MOLECULE DRUG
  • 6.2. BIOLOGIC DRUG

7. MARKET BY SERVICE

  • 7.1. DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
  • 7.2. CHEMICAL SERVICES
  • 7.3. BIOLOGICAL SERVICES
  • 7.4. OTHER PHARMACEUTICAL SERVICES

8. MARKET BY END USER

  • 8.1. RESEARCH INSTITUTES
  • 8.2. PHARMACEUTICAL COMPANIES
  • 8.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)
  • 8.4. OTHER END USER

9. KEY ANALYTICS

  • 9.1. PORTER'S FIVE FORCES MODEL
    • 9.1.1. THREATS OF NEW ENTRANTS
    • 9.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 9.1.3. BARGAINING POWER OF BUYERS
    • 9.1.4. BARGAINING POWER OF SUPPLIERS
  • 9.2. COMPETITIVE RIVALRY
  • 9.3. VALUE CHAIN ANALYSIS
  • 9.4. PESTLE ANALYSIS
  • 9.5. REGULATORY FRAMEWORK
  • 9.6. OPPORTUNITY MATRIX

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. THE UNITED STATES
    • 10.1.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. THE UNITED KINGDOM
    • 10.2.2. FRANCE
    • 10.2.3. GERMANY
    • 10.2.4. SPAIN
    • 10.2.5. ITALY
    • 10.2.6. REST OF EUROPE
  • 10.3. ASIA PACIFIC
    • 10.3.1. CHINA
    • 10.3.2. INDIA
    • 10.3.3. JAPAN
    • 10.3.4. SOUTH KOREA
    • 10.3.5. AUSTRALIA
    • 10.3.6. REST OF ASIA PACIFIC
  • 10.4. REST OF WORLD
    • 10.4.1. LATIN AMERICA
    • 10.4.2. MIDDLE EAST AND AFRICA

11. COMPANY PROFILES

  • 11.1. 3M COMPANY
  • 11.2. ANTARES PHARMA
  • 11.3. ASTRAZENECA PLC
  • 11.4. BAYER AG
  • 11.5. BECTON, DICKINSON & COMPANY (BD)
  • 11.6. BOEHRINGER INGELHEIM
  • 11.7. ELI LILY
  • 11.8. F. HOFFMANN-LA ROCHE LTD
  • 11.9. GLAXOSMITHKLINE LLC
  • 11.10. JOHNSON AND JOHNSON
  • 11.11. MERCK & CO. INC.
  • 11.12. NOVARTIS
  • 11.13. PFIZER, INC.
  • 11.14. SANOFI

LIST OF TABLES

  • TABLE 1 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 2 FACT SHEET OF GLOBAL FATALITIES
  • TABLE 3 GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 4 GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 5 GLOBAL BIOCHIPS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL BIOINFORMATICS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL PHARMACOGENOMICS AND PHARMACOGENETICS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 8 GLOBAL COMBINATORIAL CHEMISTRY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 9 GLOBAL NANOTECHNOLOGY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 10 GLOBAL SPECTROSCOPY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 11 GLOBAL METABOLOMICS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 12 GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION)
  • TABLE 14 GLOBAL SMALL MOLECULE DRUG MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 15 GLOBAL BIOLOGIC DRUG MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 16 GLOBAL DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION)
  • TABLE 17 GLOBAL DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 18 GLOBAL CHEMICAL SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 19 GLOBAL BIOLOGICAL SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 20 GLOBAL OTHER PHARMACEUTICAL SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 21 GLOBAL DRUG DISCOVERY MARKET, BY END USER, 2019-2027 ($ MILLION)
  • TABLE 22 GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 23 GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 24 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 25 GLOBAL OTHER END USER MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 26 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 27 NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 28 EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 29 ASIA PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 30 REST OF WORLD DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • FIGURE 2 GLOBAL DRUG DISCOVERY MARKET, SHARE BY TECHNOLOGY 2018 & 2027 (%)
  • FIGURE 3 GLOBAL DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION)
  • FIGURE 4 GLOBAL DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION)
  • FIGURE 5 GLOBAL DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION)
  • FIGURE 6 GLOBAL DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION)
  • FIGURE 7 GLOBAL DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION)
  • FIGURE 8 GLOBAL DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION)
  • FIGURE 10 GLOBAL DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL DRUG DISCOVERY MARKET, SHARE BY DRUG TYPE 2018 & 2027 (%)
  • FIGURE 13 GLOBAL DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION)
  • FIGURE 14 GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION)
  • FIGURE 15 GLOBAL DRUG DISCOVERY MARKET, SHARE BY SERVICE 2018 & 2027 (%)
  • FIGURE 16 GLOBAL DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES 2019-2027 ($ MILLION)
  • FIGURE 17 GLOBAL DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION)
  • FIGURE 18 GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION)
  • FIGURE 19 GLOBAL DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION)
  • FIGURE 20 GLOBAL DRUG DISCOVERY MARKET, SHARE BY END USER 2018 & 2027 (%)
  • FIGURE 21 GLOBAL DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)
  • FIGURE 22 GLOBAL DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION)
  • FIGURE 23 GLOBAL DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION)
  • FIGURE 24 GLOBAL DRUG DISCOVERY MARKET, BY OTHER END USER, 2019-2027 ($ MILLION)
  • FIGURE 25 PORTER'S FIVE FORCE MODEL
  • FIGURE 26 GLOBAL DRUG DISCOVERY MARKET, REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 27 THE UNITED STATES DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 28 CANADA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 29 THE UNITED KINGDOM DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 30 FRANCE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 31 GERMANY DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 32 SPAIN DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 33 ITALY DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 34 REST OF EUROPE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 35 CHINA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 36 INDIA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 37 JAPAN DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 38 SOUTH KOREA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 39 AUSTRALIA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 40 REST OF ASIA PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 41 LATIN AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 42 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
Back to Top